カテゴリー： QYResearch, 中国

中国の感染症検査・診断市場2022-2028

【英語タイトル】China Infectious Disease Testing And Diagnostic Market Report & Forecast 2022-2028

QYResearchが出版した調査資料（QY552LM400）・商品コード：QY552LM400
・発行会社（調査会社）：QYResearch
・発行日：2022年5月
・ページ数：約90
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：中国
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,400 ⇒換算￥516,800見積依頼/購入/質問フォーム
Multi User（1名様閲覧用）USD5,850 ⇒換算￥889,200見積依頼/購入/質問フォーム
Enterprise License（法人閲覧用）USD7,800 ⇒換算￥1,185,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

Market Analysis and Insights: China Infectious Disease Testing And Diagnostic Market
This report focuses on China Infectious Disease Testing And Diagnostic market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the China Infectious Disease Testing And Diagnostic market size is estimated to be worth US$ xx million in 2022 and is forecast to a readjusted size of US$ xx million by 2028 with a CAGR of xx% during the review period.
In the Infectious Disease Testing And Diagnostic market size is expected to grow from US$ XX million in 2021 to US$ XX million by 2028, at a CAGR of XX% during the forecast period.

Infectious Disease Testing And Diagnostic market is segmented in regional and country level, by players, by Type, and by Application. Players, stakeholders, and other participants in the China Infectious Disease Testing And Diagnostic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

By Company
 BD
 Abbott
 Roche
 Danaher
 Qiagen
 SIEMENS
 Quidel
 BioRad
 Thermo Fisher Scientific
 Wondfo
 Beijing Wantai Biological Pharmacy
 Mindray
 Autobio

Segment by Type
 Immuno Diagnostics
 Molecular Diagnostics
 Culture-Based Diagnostics
 Others

Segment by Application
 Hospitals
 Independent Testing Organizations
 Diagnostic Laboratories
 Other

❖ レポートの目次 ❖

1 Study Coverage
1.1 Infectious Disease Testing And Diagnostic Product Introduction
1.2 China Infectious Disease Testing And Diagnostic Revenue for the Year 2017-2028
1.3 Infectious Disease Testing And Diagnostic Revenue for the Year 2017-2028
1.4 Infectious Disease Testing And Diagnostic Market Dynamics
1.4.1 Infectious Disease Testing And Diagnostic Industry Trends
1.4.2 Infectious Disease Testing And Diagnostic Market Drivers
1.4.3 Infectious Disease Testing And Diagnostic Market Challenges
1.4.4 Infectious Disease Testing And Diagnostic Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Infectious Disease Testing And Diagnostic by Type
2.1 Infectious Disease Testing And Diagnostic Market Segment by Type
2.1.1 Immuno Diagnostics
2.1.2 Molecular Diagnostics
2.1.3 Culture-Based Diagnostics
2.1.4 Others
2.2 China Infectious Disease Testing And Diagnostic Revenue, by Type (2017, 2022 & 2028)
3 Infectious Disease Testing And Diagnostic by Application
3.1 Infectious Disease Testing And Diagnostic Market Segment by Application
3.1.1 Hospitals
3.1.2 Independent Testing Organizations
3.1.3 Diagnostic Laboratories
3.1.4 Other
3.2 China Infectious Disease Testing And Diagnostic Revenue, by Application (2017, 2022 & 2028)
4 Competitor Landscape by Company
4.1 China Infectious Disease Testing And Diagnostic Market Size by Company
4.1.1 China Infectious Disease Testing And Diagnostic Players Ranked by Revenue (2021)
4.1.2 China Infectious Disease Testing And Diagnostic Revenue by Player (2017-2022)
4.2 China Infectious Disease Testing And Diagnostic Manufacturing Base Distribution, Product Type
4.2.1 China Infectious Disease Testing And Diagnostic Players, Headquarters and Distribution of Producing Region
4.2.2 Players Infectious Disease Testing And Diagnostic Product Type
4.2.3 Date of Players Enter into Infectious Disease Testing And Diagnostic Market
4.3 Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 BD
5.1.1 BD Corporation Information
5.1.2 BD Description and Business Overview
5.1.3 BD in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.1.4 BD Infectious Disease Testing And Diagnostic Products Offered
5.1.5 BD Recent Development
5.2 Abbott
5.2.1 Abbott Corporation Information
5.2.2 Abbott Description and Business Overview
5.2.3 Abbott in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.2.4 Abbott Infectious Disease Testing And Diagnostic Products Offered
5.2.5 Abbott Recent Development
5.3 Roche
5.3.1 Roche Corporation Information
5.3.2 Roche Description and Business Overview
5.3.3 Roche in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.3.4 Roche Infectious Disease Testing And Diagnostic Products Offered
5.3.5 Roche Recent Development
5.4 Danaher
5.4.1 Danaher Corporation Information
5.4.2 Danaher Description and Business Overview
5.4.3 Danaher in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.4.4 Danaher Infectious Disease Testing And Diagnostic Products Offered
5.4.5 Danaher Recent Development
5.5 Qiagen
5.5.1 Qiagen Corporation Information
5.5.2 Qiagen Description and Business Overview
5.5.3 Qiagen in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.5.4 Qiagen Infectious Disease Testing And Diagnostic Products Offered
5.5.5 Qiagen Recent Development
5.6 SIEMENS
5.6.1 SIEMENS Corporation Information
5.6.2 SIEMENS Description and Business Overview
5.6.3 SIEMENS in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.6.4 SIEMENS Infectious Disease Testing And Diagnostic Products Offered
5.6.5 SIEMENS Recent Development
5.7 Quidel
5.7.1 Quidel Corporation Information
5.7.2 Quidel Description and Business Overview
5.7.3 Quidel in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.7.4 Quidel Infectious Disease Testing And Diagnostic Products Offered
5.7.5 Quidel Recent Development
5.8 BioRad
5.8.1 BioRad Corporation Information
5.8.2 BioRad Description and Business Overview
5.8.3 BioRad in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.8.4 BioRad Infectious Disease Testing And Diagnostic Products Offered
5.8.5 BioRad Recent Development
5.9 Thermo Fisher Scientific
5.9.1 Thermo Fisher Scientific Corporation Information
5.9.2 Thermo Fisher Scientific Description and Business Overview
5.9.3 Thermo Fisher Scientific in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.9.4 Thermo Fisher Scientific Infectious Disease Testing And Diagnostic Products Offered
5.9.5 Thermo Fisher Scientific Recent Development
5.10 Wondfo
5.10.1 Wondfo Corporation Information
5.10.2 Wondfo Description and Business Overview
5.10.3 Wondfo in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.10.4 Wondfo Infectious Disease Testing And Diagnostic Products Offered
5.10.5 Wondfo Recent Development
5.11 Beijing Wantai Biological Pharmacy
5.11.1 Beijing Wantai Biological Pharmacy Corporation Information
5.11.2 Beijing Wantai Biological Pharmacy Description and Business Overview
5.11.3 Beijing Wantai Biological Pharmacy in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.11.4 Beijing Wantai Biological Pharmacy Infectious Disease Testing And Diagnostic Products Offered
5.11.5 Beijing Wantai Biological Pharmacy Recent Development
5.12 Mindray
5.12.1 Mindray Corporation Information
5.12.2 Mindray Description and Business Overview
5.12.3 Mindray in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.12.4 Mindray Infectious Disease Testing And Diagnostic Products Offered
5.12.5 Mindray Recent Development
5.13 Autobio
5.13.1 Autobio Corporation Information
5.13.2 Autobio Description and Business Overview
5.13.3 Autobio in China: Infectious Disease Testing And Diagnostic Revenue and Gross Margin (2017-2022)
5.13.4 Autobio Infectious Disease Testing And Diagnostic Products Offered
5.13.5 Autobio Recent Development
6 Research Findings and Conclusion
7 Appendix
7.1 Research Methodology
7.1.1 Methodology/Research Approach
7.1.2 Data Source
7.2 Author Details
7.3 Disclaimer



★調査レポート[中国の感染症検査・診断市場2022-2028] (コード：QY552LM400)販売に関する免責事項を必ずご確認ください。
★調査レポート[中国の感染症検査・診断市場2022-2028]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界及び日本のリトレッドタイヤ市場2022-2028
  • 世界・日本のランセット市場2022-2028
  • 世界及び日本のSDメモリーカード市場2022-2028
  • 世界・日本のタキシフォリン市場2022-2028
  • 世界及び日本のPCコネクター市場2022-2028
  • 炭素繊維製自転車ホイールの世界市場2017-2028
  • 炭素繊維製自転車フレームの世界市場2017-2028
  • アルコール検知器の世界市場
  • 薬物乱用検査装置のアジア市場
  • 日本のPOC診断用PCR市場2022

    • ◆H&Iグローバルリサーチのお客様（例）◆